SEC 13F Intelligence

Aqr Capital Management LLC / ABT

Aqr Capital Management LLC’s Abbott Laboratories Position

Does Aqr Capital Management LLC own Abbott Laboratories (ABT)? Yes — 1.57M shares worth $161M (+0.07% of its 13F portfolio) as of Q1 2026, up from 1.08M shares the prior filed quarter.

Position Value
$161M
Q1 2026
Shares
1.57M
% of Portfolio
+0.07%
Quarters Held
30
currently held

Position History ABT

Reported value by quarter
Q4 ’18: $144MQ4 ’18Q1 ’19: $162MQ2 ’19: $182MQ3 ’19: $119MQ4 ’19: $77MQ4 ’19Q1 ’20: $47MQ2 ’20: $91MQ3 ’20: $138MQ4 ’20: $181MQ4 ’20Q1 ’21: $277MQ2 ’21: $243MQ3 ’21: $235MQ4 ’21: $269MQ4 ’21Q1 ’22: $223MQ2 ’22: $200MQ3 ’22: $162MQ4 ’22: $198MQ4 ’22Q1 ’23: $165MQ2 ’23: $129MQ3 ’23: $105MQ4 ’23: $88MQ4 ’23Q1 ’24: $94MQ2 ’24: $90MQ3 ’24: $150MQ4 ’24: $169MQ4 ’24Q1 ’25: $227MQ2 ’25: $252MQ3 ’25: $154MQ4 ’25: $135MQ4 ’25Q1 ’26: $161Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.57M$161M+0.07%
Q4 20251.08M$135M+0.07%
Q3 20251.16M$154M+0.10%
Q2 20251.86M$252M+0.21%
Q1 20251.72M$227M+0.23%
Q4 20241.49M$169M+0.22%
Q3 20241.33M$150M+0.21%
Q2 2024871.2K$90M+0.14%
Q1 2024832.5K$94M+0.16%
Q4 2023803.4K$88M+0.17%
Q3 20231.08M$105M+0.22%
Q2 20231.20M$129M+0.28%
Q1 20231.65M$165M+0.36%
Q4 20221.81M$198M+0.45%
Q3 20221.67M$162M+0.39%
Q2 20221.85M$200M+0.45%
Q1 20221.88M$223M+0.42%
Q4 20211.91M$269M+0.49%
Q3 20211.99M$235M+0.44%
Q2 20212.10M$243M+0.42%
Q1 20212.31M$277M+0.45%
Q4 20201.67M$181M+0.32%
Q3 20201.30M$138M+0.23%
Q2 20201.03M$91M+0.15%
Q1 2020596.9K$47M+0.08%
Q4 2019886.2K$77M+0.09%
Q3 20191.43M$119M+0.14%
Q2 20192.18M$182M+0.20%
Q1 20192.04M$162M+0.17%
Q4 20181.99M$144M+0.17%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Aqr Capital Management LLC’s full portfolio or all institutional holders of ABT.